<?xml version="1.0" encoding="UTF-8"?>
<ref id="B91-biomedicines-08-00060">
 <label>91.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Niu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Tian</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Yin</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Cao</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Q.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Recombinant newcastle disease virus expressing IL15 demonstrates promising antitumor efficiency in melanoma model</article-title>
  <source>Technol. Cancer Res. Treat.</source>
  <year>2015</year>
  <volume>14</volume>
  <fpage>607</fpage>
  <lpage>615</lpage>
  <pub-id pub-id-type="doi">10.7785/tcrt.2012.500414</pub-id>
  <pub-id pub-id-type="pmid">24645750</pub-id>
 </element-citation>
</ref>
